ISOFOL MEDICAL AB BTUISOFOL MEDICAL AB BTUISOFOL MEDICAL AB BTU

ISOFOL MEDICAL AB BTU

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪237.56 M‬SEK
−0.26SEK
‪−43.49 M‬SEK
0.00SEK
‪239.09 M‬
Beta (1Y)
0.89
Employees (FY)
5
Change (1Y)
+2 +66.67%
Revenue / Employee (1Y)
0.00SEK
Net income / Employee (1Y)
‪−8.70 M‬SEK

About ISOFOL MEDICAL AB


CEO
Petter Segelman Lindqvist
Website
Headquarters
Gothenburg
Founded
2008
ISIN
SE0025197536
FIGI
BBG01TYD6PD3
Isofol Medical AB is a biotech company, which engages in the development of the cancer drug Arfolitixorin, intended primarily for the treatment of colorectal cancer. The company was founded in 2008 by Bengt Gustaf Gustavsson and is headquartered in Gothenburg, Sweden.

Check out other big names from the same industry as ISOFOL_BTU.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ISOFOL_BTU is 10.28 SEK — it has decreased by −1.92% in the past 24 hours. Watch ISOFOL MEDICAL AB BTU stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ISOFOL MEDICAL AB BTU stocks are traded under the ticker ISOFOL_BTU.
ISOFOL_BTU stock has risen by 10.75% compared to the previous week, the month change is a 10.75% rise, over the last year ISOFOL MEDICAL AB BTU has showed a 11.62% increase.
ISOFOL_BTU stock is 3.00% volatile and has beta coefficient of 0.89. Track ISOFOL MEDICAL AB BTU stock price on the chart and check out the list of the most volatile stocks — is ISOFOL MEDICAL AB BTU there?
Today ISOFOL MEDICAL AB BTU has the market capitalization of ‪229.89 M‬, it has decreased by −6.17% over the last week.
Yes, you can track ISOFOL MEDICAL AB BTU financials in yearly and quarterly reports right on TradingView.
ISOFOL MEDICAL AB BTU is going to release the next earnings report on Jul 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ISOFOL_BTU net income for the last quarter is ‪−13.66 M‬ SEK, while the quarter before that showed ‪−13.10 M‬ SEK of net income which accounts for −4.24% change. Track more ISOFOL MEDICAL AB BTU financial stats to get the full picture.
No, ISOFOL_BTU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 4, 2025, the company has 5 employees. See our rating of the largest employees — is ISOFOL MEDICAL AB BTU on this list?
Like other stocks, ISOFOL_BTU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ISOFOL MEDICAL AB BTU stock right from TradingView charts — choose your broker and connect to your account.